ZA200800285B - Formulations for enhanced mucosal delivery of pyy - Google Patents

Formulations for enhanced mucosal delivery of pyy

Info

Publication number
ZA200800285B
ZA200800285B ZA200800285A ZA200800285A ZA200800285B ZA 200800285 B ZA200800285 B ZA 200800285B ZA 200800285 A ZA200800285 A ZA 200800285A ZA 200800285 A ZA200800285 A ZA 200800285A ZA 200800285 B ZA200800285 B ZA 200800285B
Authority
ZA
South Africa
Prior art keywords
pyy
formulations
mucosal delivery
enhanced mucosal
enhanced
Prior art date
Application number
ZA200800285A
Inventor
Henry R Constantino
Cohen Annemarie Stoudt
Mary S Kleppe
Anthony P Sileno
Original Assignee
Mdrna Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mdrna Inc filed Critical Mdrna Inc
Publication of ZA200800285B publication Critical patent/ZA200800285B/en

Links

ZA200800285A 2005-07-11 2008-01-09 Formulations for enhanced mucosal delivery of pyy ZA200800285B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69805205P 2005-07-11 2005-07-11

Publications (1)

Publication Number Publication Date
ZA200800285B true ZA200800285B (en) 2009-08-26

Family

ID=39962912

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800285A ZA200800285B (en) 2005-07-11 2008-01-09 Formulations for enhanced mucosal delivery of pyy

Country Status (2)

Country Link
CN (1) CN101262888A (en)
ZA (1) ZA200800285B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104371005A (en) * 2014-11-14 2015-02-25 中山大学 Polypeptide PP3 capable of promoting growth hormone of tilapia mossambica to express and application of polypeptide PP3

Also Published As

Publication number Publication date
CN101262888A (en) 2008-09-10

Similar Documents

Publication Publication Date Title
GB2435419B (en) Formulations
PL1888031T3 (en) Glp-1 analogue formulations
EP2046930A4 (en) Rhamnolipid-based formulations
HK1152478A1 (en) Solid pharmaceutical formulations comprising bibw 2992
IL188448A0 (en) Formulations for enhanced mucosal delivery of pyy
HRP20130109T1 (en) Caspofungin formulations
GB0605780D0 (en) Formulations
HK1180949A1 (en) Long lasting drug formulations
EP1888036A4 (en) Compositions for drug delivery
IL194366A0 (en) Solid dosage formulations
GB0618697D0 (en) Formulations
EP2001400A4 (en) Oral formulations of glycyl-2-methylprolyl-glutamate
GB0610336D0 (en) Formulations
GB0615108D0 (en) Novel formulations
ZA200807486B (en) Medicament formulations comprising fluoroquinolones
EP1841451A4 (en) Peptides for delivery of mucosal vaccines
IL198760A0 (en) Oral formulations
IL198160A0 (en) Pharmaceutical formulations
ZA200800285B (en) Formulations for enhanced mucosal delivery of pyy
GB0718404D0 (en) Formulations
ZA200807682B (en) Novel formulations
GB0615461D0 (en) Pharmaceutical formulations
GB0623791D0 (en) Formulations
GB0618691D0 (en) Formulations
GB0611519D0 (en) Formulations